242 filings
Page 11 of 13
8-K
y7zyt74bp48p4b2z9
8 Jun 17
CRISPR Therapeutics Appoints James R. Kasinger as General Counsel
12:00am
8-K
cgebw j7irzgq1yk
2 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
oeadm8x32p2z13pevszf
11 May 17
Results of Operations and Financial Condition
12:00am
8-K
cjrlfcat6ltx2wfy
4 May 17
Departure of Directors or Certain Officers
12:00am
8-K
4rebngfm7ht
27 Apr 17
Intellia Therapeutics and CRISPR Therapeutics Announce
12:00am
DEFA14A
lwz35i r9bb4lk
18 Apr 17
Additional proxy soliciting materials
12:00am
DEF 14A
jrsat
18 Apr 17
Definitive proxy
12:00am
8-K
lz18jyygn6p8u
13 Apr 17
CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Appeal of CRISPR/Cas9 U.S. Patent Board Decision
12:00am
PRE 14A
l39rok79ftlmh32a2
4 Apr 17
Preliminary proxy
12:00am
8-K
81ea rz5fk7quzg8drn
31 Mar 17
CRISPR Therapeutics Announces European Patent
12:00am
8-K
qjtmiq9bx
20 Mar 17
Departure of Directors or Certain Officers
12:00am
10-K
6f7pt0mp5i6029e
10 Mar 17
Annual report
12:00am
8-K
8s2og7d fnmr
15 Feb 17
Other Events
12:00am
CT ORDER
7f06wnie9t
13 Jan 17
Confidential treatment order
12:00am
8-K
rfu cpjf7v5z5jryz
16 Dec 16
Entry into a Material Definitive Agreement
12:00am
10-Q
nvuounzuk6hchy627qy3
22 Nov 16
Quarterly report
12:00am
8-K
dyeiq
8 Nov 16
Amendments to Articles of Incorporation or Bylaws
12:00am
D
xd60k67u9kqteerq4rui
4 Nov 16
$35M in equity, sold $35M, 1 investor
12:00am
S-8
j93yc0 ae
20 Oct 16
Registration of securities for employees
12:00am